The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses.
Stefan G Hofmann, Anu Asnaani, Imke J J Vonk...
https://pubmed.ncbi.nlm.nih.gov/23459093Actively Recruiting
Phase Not Applicable
Age: 18Years - 70Years
All Genders
ID07255131
The Effectiveness and Efficacy of an Online Group Cognitive Behavioral Psychotherapy in Patients With Cystic Fibrosis and Caregivers Compared to Control Groups
Led by Rakitzi, Stavroula · Updated on 2026-01-27
52
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the effectiveness of an online group cognitive behavioral psychotherapeutic program for patients with cystic fibrosis and their caregivers. This randomized controlled trial compares this program with an online group supportive psychotherapeutic program to understand how these therapies impact depression, anxiety, recovery, and functional outcomes. The study is sponsored by Stavroula Rakitzi and conducted by the Hellenic Cystic Fibrosis Association. Participants are divided into four groups: two therapy groups receiving the cognitive behavioral psychotherapy and two control groups receiving supportive psychotherapy. Each group participates in 13 weekly sessions conducted online via Zoom. One therapy and one control group consist of patients with cystic fibrosis, while the other therapy and control groups include caregivers of these patients. Throughout the study, participants will complete various assessments at three points: before the intervention, immediately after, and up to 24 weeks after completion. These assessments include measures of symptoms, uncertainty, depression, disability, and recovery. The study carefully monitors participant progress and outcomes to evaluate the therapy programs. Total participation spans the duration of the 13 sessions plus follow-up assessments over 24 weeks.
CONDITIONS
Brief Title
The Effectiveness and Efficacy of an Online Cognitive Behavioral Psychotherapeutic Program
Who Can Participate
Age: 18Years - 70Years
All Genders
Eligibility Criteria
You may qualify if you...
- Age 18-70 years
- Members of the Hellenic Cystic Fibrosis Association
- Willingness to participate in 13 weekly sessions via Zoom
You will not qualify if you...
- Age over 70 years
- Not a member of the Hellenic Cystic Fibrosis Association
- Unable to participate in 13 weekly sessions via Zoom
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or online) for eligibility assessment
Outpatient Treatment
Duration - 13 weeks
Participants attend 13 weekly online group psychotherapy sessions via Zoom, either cognitive behavioral therapy or supportive psychotherapy, depending on their group assignment.
Weekly sessions for 13 weeks via Zoom
Follow-up
Duration - Up to 24 weeks after treatment
Participants complete follow-up assessments up to 24 weeks after the intervention to evaluate the lasting effects of the psychotherapy program.
Assessments at immediate post-intervention and follow-up visits up to 24 weeks
Trial Site Locations
Total: 1 location
1
Private practice, ILISION 34 15771 Athens Greece
Athens, Greece, 15771
Actively Recruiting
Loading map...
Research Team
D
Dr. Stavroula Rakitzi, PhD
M
Mrs Anna Spinou, President of the Hellenic Cystic Fibrosis Association, Msc
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Recovery Assessment Scale - Domains and Stages (RAS-DS): Its feasibility and outcome measurement capacity.
Nicola Hancock, Justin Newton Scanlan, Anne Honey...
https://pubmed.ncbi.nlm.nih.gov/25526940A rating scale for depression.
M HAMILTON
https://pubmed.ncbi.nlm.nih.gov/14399272The Greek translation of the symptoms rating scale for depression and anxiety: preliminary results of the validation study.
Konstantinos N Fountoulakis, Apostolos Iacovides, Soula Kleanthous...
https://pubmed.ncbi.nlm.nih.gov/14667249